EU Opens Public Consultation on Biotech Act II, Targeting Industrial Fermentation and Biomanufacturing
The European Commission’s call for evidence on its proposed Biotech Act II has drawn responses from across the alternative protein and industrial biotech sectors, with companies urging clearer regulatory pathways for fermentation-derived ingredients, cultivated biomass, and precision fermentation ahead of the June 10 deadline. The regulation, expected as a legislative proposal in Q4 2026, would extend the EU’s biotech framework beyond health biotechnology to cover industrial biotechnology and biomanufacturing. The …
The Protein Brewery’s Fermotein Receives EFSA Green Light
The Protein Brewery has reached a milestone in its efforts to introduce its innovative food ingredient, Fermotein®, to the European market. The company announced today that the European Food Safety Authority (EFSA) has issued a positive scientific opinion on Fermotein®, a novel food ingredient derived from fermented fungal biomass. Fermotein®, a mycoprotein powder, is produced using the Rhizomucor pusillus strain. It is rich in protein, fiber, vitamins, and minerals, positioning …
Vivici Secures US Production for Precision-Fermented Dairy Protein via Liberation Labs Deal
Vivici, a Dutch precision fermentation company, has secured a manufacturing partnership with US-based Liberation Labs for the production of its beta-lactoglobulin (BLG) protein ingredient, Vivitein™. The agreement will see Vivici’s product manufactured at Liberation Labs’ new facility in Richmond, Indiana, with commercial-scale output expected to begin in 2026. The Richmond site is Liberation Labs’ first commercial-scale biomanufacturing facility, currently under construction. It will feature 600,000 liters of fermentation capacity and …